When was Diligent founded?

Diligent was founded in 2018 and raised its 1st funding round 5 years after it was founded.

Where is Diligent located?

Diligent is headquartered in Princeton, United States.

How many employees does Diligent have?

As of Sep 30, 2026, the latest employee count at Diligent is 27.

Is Diligent a funded company?

Diligent is a funded company, having raised a total of $***** in its 1st and only funding round, a Series A round on May 15, 2023.

When was the latest funding round of Diligent?

Diligent's latest funding was a $***** Series A round on May 15, 2023, with participation from 3 investors.

Where does Diligent rank among its competitors?

Diligent ranks 30th amongst 209 active competitors, of which 5 are funded. It stands 1st in terms of total funding among its competitors. The most recent competitor to raise funding was PharmAla Biotech, which secured $1.09M in Dec, 2024.

Who are the top competitors of Diligent?

Diligent's top competitors include Vasta Global, PharmAla Biotech and S-Cubed. Among them, PharmAla Biotech secured the most recent funding round in December, 2024.

Diligent - 2026 Company Profile, Funding & Competitors

Company Details

Website: www.diligentpharma.com/
Social

Key Metrics

Founded Year

2018

Location

Princeton, United States

Stage

Series A

Total Funding

$8.27M in 1 round

Latest Funding Round

Series A, May 15, 2023, $*****

Investors

FCA Venture Partners & 2 more

Ranked

30^th among 209 active competitors

Employee Count

27 as on Sep 30, 2026

Similar Companies

Vasta Global & 250 more

View Diligent's full profile

Diligent is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Reports
DILIGENT PHARMA, LLC CIN: 832154775 , United States, Active	Dec 31, 1999	-	17 (As on Dec 31, 2024)	-

Diligent has raised a total funding of $8.27M over 1 round. Its latest funding round was a Series A round on May 15, 2023 for $*****. 3 investors participated in its latest round. Diligent has 3 institutional investors.

Here is the list of recent funding rounds of Diligent:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
May 15, 2023	7142883	Series A	3612886	3659101	2297616	2772106

Access funding benchmarks and valuations. Sign up today!

View details of Diligent's funding rounds and investors

Diligent's employee count trend

Diligent has 27 employees as of Sep 26. Here is Diligent's employee count trend over the years:

Uncover Diligent's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Diligent include Vasta Global, PharmAla Biotech and S-Cubed. Here is the list of Top 10 competitors of Diligent, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Vasta Global 2010, Mumbai (India), Acquired	Offers clinical research consulting	-	-	57/100
2nd	PharmAla Biotech 2021, Toronto (Canada), Public	Provider of biomanufacturing, regulatory, and financial services	-	-	43/100
3rd	S-Cubed 2007, Copenhagen (Denmark), Acquired	Clinical development consultancy services in areas such as biometrics, CDISC, and regulatory affairs	-	-	42/100
4th	Biomapas 2001, Kaunas (Lithuania), Acquired	Manufacturer of clinical research for medical devices	-	Carbyne Equity Partners	40/100
5th	Blue Matter Consulting 2012, San Francisco (United States), Late Stage	Provider of consulting services focused for clinical drug development	-	Baird Capital	38/100
6th	Cerveau Technologies 2015, Boston (United States), Acquired	Innovating PET imaging agents for Alzheimer's disease research and diagnostics	-	-	36/100
7th	Orchestra Life Sciences 2021, Chesterfield (United States), Unfunded	Provider of technical consultancy for cancer and rare disease therapies	-	-	36/100
8th	MCRA 2004, New York City (United States), Funding Raised	Provider of regulatory, quality assurance and market access services to biopharma sector	-	Caltius Capital Management, Viscogliosi Brothers	35/100
9th	CHDR 1987, Leiden (Netherlands), Funding Raised	Early-stage clinical drug research services	-	Europa	34/100
10th	CATALIS 2017, Montreal (Canada), Seed	Provider of consulting services for clinical drug development	$1.18M	AbbVie, Takeda & 6 others	34/100
30th	Diligent 2018, Princeton (United States), Series A	Provider of contract based clinical trial and quality management services	$8.27M	PJC, FCA Venture Partners & 1 others	30/100